Berberine Attenuates Obesity-Induced Adipose Tissue R
Berberine is a plant-derived isoquinoline alkaloid with anti-inflammatory and metabolic regulatory properties. Nevertheless, its role in immune–vascular remodeling in obese adipose tissue remains unclear. This study investigated whether berberine ameliorates obesity-induced adipose tissue remodeling by regulating macrophage activation and vascular dysfunction in a high-fat diet (HFD)-induced obesity model. Male C57BL/6 mice were assigned to normal diet, HFD, or HFD plus berberine treatment groups for eight weeks. Whole-mount immunofluorescence staining, vascular permeability assays, ELISA, and quantitative real-time PCR were performed using epididymal adipose tissue. HFD feeding markedly increased adipocyte hypertrophy, PECAM-1-positive vascular expansion, vascular leakage, and macrophage infiltration. Berberine significantly reduced adipocyte enlargement, pathological vascular remodeling, and Evans blue dye extravasation, indicating improved endothelial barrier integrity. Berberine also suppressed M1-associated (TNF-α, IL-1β, CD11c, and CCL2) and M2-associated (arginase-1, CD206, Fizz1, and TGF-β1) macrophage markers, suggesting the inhibition of global macrophage hyperactivation rather than phenotype-specific polarization. LYVE-1-positive cells were minimally affected by the berberine treatment. Hence, berberine alleviates obesity-associated adipose tissue inflammation through coordinated attenuation of macrophage-driven inflammatory responses and pathological vascular remodeling.